(Q42670982)

English

Evaluation of the long-term cost-effectiveness of insulin detemir compared with neutral protamine hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in Sweden

scientific article published on August 5, 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Evaluation of the long-term cost-effectiveness of insulin detemir compared with neutral protamine hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in Sweden (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

type-1 diabetes

0 references

0 references

1 reference

based on heuristic

inferred from title

insulin detemir

1 reference

based on heuristic

inferred from title

4

object named as

Asa Ericsson

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

author name string

Mark Aagren

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Mattias Haglund

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

William J. Valentine

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20688795

17 June 2024

Asa Ericsson

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20688795

17 June 2024

Manuela H. Gschwend

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20688795

17 June 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20688795

17 June 2024

publication date

5 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

full work available at URL

http://journals.sagepub.com/doi/pdf/10.1177/1403494810379290

1 reference

10.1177/1403494810379290

https://api.crossref.org/works/10.1177/1403494810379290

17 June 2024

Scandinavian Journal of Public Health

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

39

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

79-87

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group

1 reference

https://api.crossref.org/works/10.1177%2F1403494810379290

21 January 2018

Diabetes, healthcare cost and loss of productivity in Sweden 1987 and 2005--a register-based approach.

1 reference

https://api.crossref.org/works/10.1177%2F1403494810379290

21 January 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1177%2F1403494810379290

21 January 2018

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1403494810379290

21 January 2018

Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart

1 reference

https://api.crossref.org/works/10.1177%2F1403494810379290

21 January 2018

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1177%2F1403494810379290

21 January 2018

Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen

1 reference

https://api.crossref.org/works/10.1177%2F1403494810379290

21 January 2018

Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F1403494810379290

21 January 2018

Guidelines for computer modeling of diabetes and its complications

1 reference

https://api.crossref.org/works/10.1177%2F1403494810379290

21 January 2018

The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making

1 reference

https://api.crossref.org/works/10.1177%2F1403494810379290

21 January 2018

Outcomes of diabetes care: a population-based study

1 reference

https://api.crossref.org/works/10.1177%2F1403494810379290

21 January 2018

Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62).

1 reference

https://api.crossref.org/works/10.1177%2F1403494810379290

21 January 2018

One thousand health-related quality-of-life estimates

1 reference

https://api.crossref.org/works/10.1177%2F1403494810379290

21 January 2018

Psychological status of diabetic people with or without lower limb disability.

1 reference

https://api.crossref.org/works/10.1177%2F1403494810379290

21 January 2018

Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes.

1 reference

https://api.crossref.org/works/10.1177%2F1403494810379290

21 January 2018

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).

1 reference

https://api.crossref.org/works/10.1177%2F1403494810379290

21 January 2018

Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: a randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy.

1 reference

https://api.crossref.org/works/10.1177%2F1403494810379290

21 January 2018

Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1177%2F1403494810379290

21 January 2018

Improving life expectancy and decreasing the incidence of complications associated with type 2 diabetes: a modelling study of HbA1c targets

1 reference

https://api.crossref.org/works/10.1177%2F1403494810379290

21 January 2018

Applications of economic models in healthcare: the introduction of pioglitazone in Sweden

1 reference

https://api.crossref.org/works/10.1177%2F1403494810379290

21 January 2018

The effects of treatment on the direct costs of diabetes

5

1 reference

10.1177/1403494810379290

https://api.crossref.org/works/10.1177/1403494810379290

17 June 2024

Validation of the CORE Diabetes Model against epidemiological and clinical studies

13

1 reference

10.1177/1403494810379290

https://api.crossref.org/works/10.1177/1403494810379290

17 June 2024

Glycemic and risk factor control in type 1 diabetes: results from 13,612 patients in a national diabetes register

15

1 reference

10.1177/1403494810379290

https://api.crossref.org/works/10.1177/1403494810379290

17 June 2024

Cost effectiveness of Becaplermin in the treatment of diabetic foot ulcers in four European countries

24

1 reference

10.1177/1403494810379290

https://api.crossref.org/works/10.1177/1403494810379290

17 June 2024

Primary and subsequent coronary risk appraisal: New results from the Framingham study

26

1 reference

10.1177/1403494810379290

https://api.crossref.org/works/10.1177/1403494810379290

17 June 2024

Profile for estimating risk of heart failure

28

1 reference

10.1177/1403494810379290

https://api.crossref.org/works/10.1177/1403494810379290

17 June 2024

An economic assessment of analogue basal-bolus insulin versus human basal-bolus insulin in subjects with type 1 diabetes in the UK

31

1 reference

10.1177/1403494810379290

https://api.crossref.org/works/10.1177/1403494810379290

17 June 2024

Cost-effectiveness of detemir-based basal/bolus therapy versus NPH-based basal/bolus therapy for type 1 diabetes in a UK setting: an economic analysis based on meta-analysis results of four clinical trials

32

1 reference

10.1177/1403494810379290

https://api.crossref.org/works/10.1177/1403494810379290

17 June 2024

Identifiers

10.1177/1403494810379290

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42670982&oldid=2183918741"